Life Sciences
From Fragmented to Submission-Ready: How One Global Pharma Company Centralized Clinical Translations
Centralizing clinical translation operations across a global pharmaceutical organization is…
Safety Signals Are Speaking Every Language. Are You Listening?
At last month’s 5th Pharmacovigilance & Drug Safety Conference in…
What It Feels Like to Wait for a Treatment That Doesn’t Exist
One patient’s journey through rare disease diagnosis, clinical trial participation,…
Clinical Trials Are Complex. Workflows Shouldn’t Make Them Harder.Â
As clinical trials scale across systems, vendors, countries, and languages,…
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.Â
Patient recruitment has always been one of the most challenging…
Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global ComplianceÂ
This is the environment where life sciences translation, regulatory content…
Creating a Future-Ready Model for a Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
Multilingual Training Made Simple for Life Sciences Leader
Delivering a 50-minute training video subtitled in 13 languages as…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
Regulatory Compliance in Pharmacovigilance Translations: EMA, FDA, and MHRA Requirements Explained
As the range of medicinal products grows, regulatory bodies such…
EUDAMED and the New Reality for Medical Device Companies
What increased transparency means for post-market surveillance and multilingual compliance.
CASE STUDY: Creating a Future-Ready Model for Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
From Pressure to Possibility: Key Insights from our MedTech Roundtable
Anja Schaefer, Welocalize Global Head of Commercial for Life Sciences,…
The Silent Bottleneck in Clinical Trials
How translation delays jeopardize First-Patient-In, regulatory submissions, and trial start-up…
CASE STUDY: Multilingual Training Made Simple for Life Sciences Leader
Delivering a 50-minute training video subtitled in 13 languages as…